Is This Beaten-Down Stock a Buy in a Post-Pandemic World?
There's a laundry list of companies that benefited from the global lockdowns which arose because of the COVID-19 pandemic. Among the top ones on that list is virtual healthcare company Teladoc Health (NYSE: TDOC).
But now that the economy has reopened in many parts of the world, the telehealth business has taken a turn for the worse. Its stock has nosedived 78% in the past year, and investors are really beginning to question the company's long-term business trajectory.
Is Teladoc just another pandemic winner that doesn't stand a chance in the post-pandemic world, or will the company get back on track in the years to follow? Let's take a look.
Source Fool.com
